NDC properties for "testosterone cypionate 1000 MG per 10 ML Injectable Solution" (RxCUI 835829)
About this data
The tables show NDC propoerties for testosterone cypionate 1000 MG per 10 ML Injectable Solution with the RxCUI 835829
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for testosterone cypionate 1000 MG per 10 ML Injectable Solution (RxCUI 835829)
| ANDA | ANDA040615 |
|---|---|
| ANDA | ANDA085635 |
| ANDA | ANDA201720 |
| ANDA | ANDA210362 |
| ANDA | ANDA211817 |
| ANDA | ANDA215351 |
| MMSL_CODE | BD2934 |
| MMSL_CODE | CD2934 |
| RxCUI | 835829 |
| SPL_SET_ID | 3653a602-4551-4e6c-84a7-31861f5dc482 |
| SPL_SET_ID | 6909596e-4bf7-4e11-8029-b89740a30aec |
| SPL_SET_ID | 78d55bad-4a5b-4e21-aeb8-a4c6346208be |
| SPL_SET_ID | a34023dc-fc54-4f66-bab0-9596502c23a3 |
| SPL_SET_ID | cab949ca-fde9-c5a9-5561-21e98d86d078 |
| SPL_SET_ID | f901e2b2-f143-4237-8e95-0d134585490b |
| VUID | 4001128 |
| Prescribable Synonym | testosterone cypionate 100 MG/ML Injectable Solution |
| RXNAV_STR | testosterone cypionate 100 MG/ML Injectable Solution |
| RxNorm Name | testosterone cypionate 100 MG/ML Injectable Solution |
| RxNorm Synonym | testosterone cypionate 1000 MG per 10 ML Injectable Solution |
| Related queries | Interactions (for RxCUI 835829) |
NDC Properties
NDC Item 00409655701
| NDC 9 | 0409-6557 |
|---|---|
| NDC 10 | 0409-6557-01 |
| NDC Item | 00409655701 |
| Packaging | 1 VIAL in 1 CARTON (0409-6557-01) / 10 mL in 1 VIAL |
| ANDA | ANDA085635 |
| DCSA | CIII |
| FDA SPL set id | 500095 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-08-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-6557 |
NDC Item 55150027601
| NDC 9 | 55150-276 |
|---|---|
| NDC 10 | 55150-276-01 |
| NDC Item | 55150027601 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-276-01) / 10 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA211817 |
| DCSA | CIII |
| FDA SPL set id | 739422 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-10-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-276 |
NDC Item 62756001740
| NDC 9 | 62756-017 |
|---|---|
| NDC 10 | 62756-017-40 |
| NDC Item | 62756001740 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (62756-017-40) / 10 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA201720 |
| DCSA | CIII |
| FDA SPL set id | 581578 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2013-06-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62756-017 |
NDC Item 69097053637
| NDC 9 | 69097-536 |
|---|---|
| NDC 10 | 69097-536-37 |
| NDC Item | 69097053637 |
| Packaging | 10 mL in 1 VIAL, GLASS (69097-536-37) |
| ANDA | ANDA210362 |
| COLORTEXT | WHITE("A clear colourless to pale yellow solution) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 729362 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-09-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69097-536 |
NDC Item 70700028822
| NDC 9 | 70700-288 |
|---|---|
| NDC 10 | 70700-288-22 |
| NDC Item | 70700028822 |
| Packaging | 1 VIAL in 1 CARTON (70700-288-22) / 10 mL in 1 VIAL |
| ANDA | ANDA215351 |
| DCSA | CIII |
| FDA SPL set id | 708164 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-288 |
NDC Item 00409655701
| NDC 9 | 0409-6557 |
|---|---|
| NDC 10 | 0409-6557-01 |
| NDC Item | 00409655701 |
| Packaging | 1 VIAL in 1 CARTON (0409-6557-01) / 10 mL in 1 VIAL |
| ANDA | ANDA085635 |
| DCSA | CIII |
| FDA SPL set id | 500095 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-08-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-6557 |
NDC Item 55150027601
| NDC 9 | 55150-276 |
|---|---|
| NDC 10 | 55150-276-01 |
| NDC Item | 55150027601 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-276-01) / 10 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA211817 |
| DCSA | CIII |
| FDA SPL set id | 739422 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-10-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-276 |
NDC Item 62756001740
| NDC 9 | 62756-017 |
|---|---|
| NDC 10 | 62756-017-40 |
| NDC Item | 62756001740 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (62756-017-40) / 10 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA201720 |
| DCSA | CIII |
| FDA SPL set id | 581578 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2013-06-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62756-017 |
NDC Item 69097053637
| NDC 9 | 69097-536 |
|---|---|
| NDC 10 | 69097-536-37 |
| NDC Item | 69097053637 |
| Packaging | 10 mL in 1 VIAL, GLASS (69097-536-37) |
| ANDA | ANDA210362 |
| COLORTEXT | WHITE("A clear colourless to pale yellow solution) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 729362 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-09-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69097-536 |
NDC Item 70700028822
| NDC 9 | 70700-288 |
|---|---|
| NDC 10 | 70700-288-22 |
| NDC Item | 70700028822 |
| Packaging | 1 VIAL in 1 CARTON (70700-288-22) / 10 mL in 1 VIAL |
| ANDA | ANDA215351 |
| DCSA | CIII |
| FDA SPL set id | 708164 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-288 |
NDC Item 00409655701
| NDC 9 | 0409-6557 |
|---|---|
| NDC 10 | 0409-6557-01 |
| NDC Item | 00409655701 |
| Packaging | 1 VIAL in 1 CARTON (0409-6557-01) / 10 mL in 1 VIAL |
| ANDA | ANDA085635 |
| DCSA | CIII |
| FDA SPL set id | 500095 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-08-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-6557 |
NDC Item 55150027601
| NDC 9 | 55150-276 |
|---|---|
| NDC 10 | 55150-276-01 |
| NDC Item | 55150027601 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-276-01) / 10 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA211817 |
| DCSA | CIII |
| FDA SPL set id | 739422 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-10-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-276 |
NDC Item 62756001740
| NDC 9 | 62756-017 |
|---|---|
| NDC 10 | 62756-017-40 |
| NDC Item | 62756001740 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (62756-017-40) / 10 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA201720 |
| DCSA | CIII |
| FDA SPL set id | 581578 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2013-06-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62756-017 |
NDC Item 69097053637
| NDC 9 | 69097-536 |
|---|---|
| NDC 10 | 69097-536-37 |
| NDC Item | 69097053637 |
| Packaging | 10 mL in 1 VIAL, GLASS (69097-536-37) |
| ANDA | ANDA210362 |
| COLORTEXT | WHITE("A clear colourless to pale yellow solution) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 729362 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-09-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69097-536 |
NDC Item 70700028822
| NDC 9 | 70700-288 |
|---|---|
| NDC 10 | 70700-288-22 |
| NDC Item | 70700028822 |
| Packaging | 1 VIAL in 1 CARTON (70700-288-22) / 10 mL in 1 VIAL |
| ANDA | ANDA215351 |
| DCSA | CIII |
| FDA SPL set id | 708164 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-288 |
NDC Item 00409655701
| NDC 9 | 0409-6557 |
|---|---|
| NDC 10 | 0409-6557-01 |
| NDC Item | 00409655701 |
| Packaging | 1 VIAL in 1 CARTON (0409-6557-01) / 10 mL in 1 VIAL |
| ANDA | ANDA085635 |
| DCSA | CIII |
| FDA SPL set id | 500095 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-08-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-6557 |
NDC Item 55150027601
| NDC 9 | 55150-276 |
|---|---|
| NDC 10 | 55150-276-01 |
| NDC Item | 55150027601 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-276-01) / 10 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA211817 |
| DCSA | CIII |
| FDA SPL set id | 739422 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-10-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-276 |
NDC Item 62756001740
| NDC 9 | 62756-017 |
|---|---|
| NDC 10 | 62756-017-40 |
| NDC Item | 62756001740 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (62756-017-40) / 10 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA201720 |
| DCSA | CIII |
| FDA SPL set id | 581578 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2013-06-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62756-017 |
NDC Item 69097053637
| NDC 9 | 69097-536 |
|---|---|
| NDC 10 | 69097-536-37 |
| NDC Item | 69097053637 |
| Packaging | 10 mL in 1 VIAL, GLASS (69097-536-37) |
| ANDA | ANDA210362 |
| COLORTEXT | WHITE("A clear colourless to pale yellow solution) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 729362 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-09-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69097-536 |
NDC Item 70700028822
| NDC 9 | 70700-288 |
|---|---|
| NDC 10 | 70700-288-22 |
| NDC Item | 70700028822 |
| Packaging | 1 VIAL in 1 CARTON (70700-288-22) / 10 mL in 1 VIAL |
| ANDA | ANDA215351 |
| DCSA | CIII |
| FDA SPL set id | 708164 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-288 |
NDC Item 00409655701
| NDC 9 | 0409-6557 |
|---|---|
| NDC 10 | 0409-6557-01 |
| NDC Item | 00409655701 |
| Packaging | 1 VIAL in 1 CARTON (0409-6557-01) / 10 mL in 1 VIAL |
| ANDA | ANDA085635 |
| DCSA | CIII |
| FDA SPL set id | 500095 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-08-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-6557 |
NDC Item 55150027601
| NDC 9 | 55150-276 |
|---|---|
| NDC 10 | 55150-276-01 |
| NDC Item | 55150027601 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-276-01) / 10 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA211817 |
| DCSA | CIII |
| FDA SPL set id | 739422 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-10-20 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-276 |
NDC Item 62756001740
| NDC 9 | 62756-017 |
|---|---|
| NDC 10 | 62756-017-40 |
| NDC Item | 62756001740 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (62756-017-40) / 10 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA201720 |
| DCSA | CIII |
| FDA SPL set id | 581578 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2013-06-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62756-017 |
NDC Item 69097053637
| NDC 9 | 69097-536 |
|---|---|
| NDC 10 | 69097-536-37 |
| NDC Item | 69097053637 |
| Packaging | 10 mL in 1 VIAL, GLASS (69097-536-37) |
| ANDA | ANDA210362 |
| COLORTEXT | WHITE("A clear colourless to pale yellow solution) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 729362 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-09-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 69097-536 |
NDC Item 70700028822
| NDC 9 | 70700-288 |
|---|---|
| NDC 10 | 70700-288-22 |
| NDC Item | 70700028822 |
| Packaging | 1 VIAL in 1 CARTON (70700-288-22) / 10 mL in 1 VIAL |
| ANDA | ANDA215351 |
| DCSA | CIII |
| FDA SPL set id | 708164 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-28 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-288 |